Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV), one of the well-known companies in the nation announced financial results as well as business updates of 2014. The Chief Executive Officer of Invivo, Mark Perrin, announced the results in a grand event a few days ago.
What CEO Had To Say:
Market conditions were supportive for the company in the previous year. Perrin states that 2014 supported Invivo in every sense. It not only achieved financial milestones, but ensured that operational efficiency touched new heights as well. If the recent past is taken into consideration, then it can be said that last 15 months were very good for the company. It is in way better situation to execute its corporate plans and projects than it was 15 months ago. The primary mission of Invivo i.e. redefining the life of cord injury patients looks within reach now. Perrin ended his statement saying that the previous year was good, and Invivo would continue the same performance in the coming months as well.
Hiring Senior Management Team Is Key To Success:
Invivo’s initial target in the previous year was to solidify its senior management; hence, it took a few revolutionary steps to hire five corporate officers after January 2014. It proved to be a great step and led the company to profitable year end results.
Execution of Pilot Trial With Neuro-Spinal Scaffold:
It executed first pilot trial in the previous year, with the help of Neuro-Spinal Scaffold. As a result of this subject, company witnessed revolutionary changes in the sensory and motor functions of the first subject. Apart from this, Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) also improved bladder function and recovered bowel function without any hassle. After successful execution of first ever pilot trial in the previous year, it executed the second trial in January 2015.
As per the management announcement, there are a lot more decisions in their way in 2015.